My post was in response to BIEL’s cost of obtaining FDA 510k clearances.
I was specifically responding to the notion that “Most Companies Would Have Spent 5-Times As Much!! Biel Did This Cheap!!” I don't believe that to be an accurate statement, and far from the truth.
Other than having tens of billions of shares outstanding, and millions of ill-gotten convertible notes on the balance sheet, I guess it’s as you state “All the bs is IN THE PAST.”